Sectors

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

SoftBank and PayPal helped the payments platform raise a series B round, which will be used to further boost the expansion of its digital ecosystem.

SoftBank Vision Fund has returned to back the e-learning portal in a round which valued it at $3.44bn and lifted its overall funding to about $860m.

GV was among the participants in a series C round that boosted the neurological communication technology developer's total funding to more than $360m.

Porsche was among the investors that supplied $75m to take the satellite launch vehicle developer's latest round to over $165m.

Salesforce and Twilio backed the API platform developer in a series D round led by Lone Pine Capital, bringing its overall funding to $315m.

The transport provider is merging with publicly-listed Queen's Gambit Growth Capital at a $1.5bn valuation, with Zain and Agility both investing.

The Slack Fund-backed password management technology developer has raised a series B round that valued it at $2bn post-money.